Damora Therapeutics, Inc. (DMRA)
30.74
+0.43
(+1.42%)
USD |
NASDAQ |
Aug 25, 16:00
30.74
0.00 (0.00%)
After-Hours: 19:59
Damora Therapeutics Price : 30.74 for Aug. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 30.67 | 31.49 | 29.70 | 30.31 | 319818.0 |
| Aug 21, 2026 | 30.45 | 31.38 | 30.14 | 30.82 | 159911.0 |
| Aug 20, 2026 | 31.84 | 32.07 | 30.12 | 30.31 | 226536.0 |
| Aug 19, 2026 | 32.43 | 33.56 | 31.41 | 32.44 | 486698.0 |
| Aug 18, 2026 | 30.74 | 32.17 | 30.29 | 31.80 | 485659.0 |
| Aug 17, 2026 | 31.10 | 31.79 | 30.81 | 31.09 | 362726.0 |
| Aug 14, 2026 | 30.37 | 31.52 | 29.50 | 31.04 | 260656.0 |
| Aug 13, 2026 | 31.13 | 31.13 | 30.16 | 30.73 | 227791.0 |
| Aug 12, 2026 | 30.29 | 31.55 | 29.89 | 31.00 | 314351.0 |
| Aug 11, 2026 | 29.89 | 30.78 | 29.14 | 30.36 | 234884.0 |
| Aug 10, 2026 | 29.72 | 30.31 | 29.22 | 29.54 | 216197.0 |
| Aug 07, 2026 | 30.11 | 30.66 | 29.09 | 29.92 | 197365.0 |
| Aug 06, 2026 | 30.44 | 31.10 | 29.39 | 29.88 | 696407.0 |
| Aug 05, 2026 | 30.55 | 31.77 | 29.05 | 30.83 | 607293.0 |
| Aug 04, 2026 | 28.85 | 30.58 | 28.48 | 30.02 | 551119.0 |
| Aug 03, 2026 | 29.67 | 29.90 | 28.42 | 28.56 | 227770.0 |
| Jul 31, 2026 | 29.21 | 30.27 | 28.65 | 28.99 | 314511.0 |
| Jul 30, 2026 | 29.05 | 30.02 | 28.71 | 29.21 | 334001.0 |
| Jul 29, 2026 | 29.42 | 30.05 | 28.16 | 28.33 | 323119.0 |
| Jul 28, 2026 | 29.53 | 30.44 | 28.40 | 29.42 | 305472.0 |
| Jul 27, 2026 | 29.98 | 30.90 | 29.02 | 29.44 | 547179.0 |
| Jul 24, 2026 | 29.79 | 30.00 | 28.48 | 28.82 | 564906.0 |
| Jul 23, 2026 | 29.28 | 30.75 | 28.25 | 29.17 | 488960.0 |
| Jul 22, 2026 | 32.63 | 33.29 | 29.54 | 29.99 | 587259.0 |
| Jul 21, 2026 | 32.68 | 34.74 | 31.94 | 32.99 | 436638.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 30.58 |
| Alnylam Pharmaceuticals, Inc. | 239.95 |
| Anika Therapeutics, Inc. | 21.52 |
| Savara, Inc. | 5.59 |
| Vericel Corp. | 43.17 |
Price Related Metrics
| PEG Ratio | -0.0003 |
| Price to Book Value | 4.917 |
| Earnings Yield | -405.9% |
| Market Cap | 1.898B |
| PEGY Ratio | -0.0003 |